GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
118
c/glp1canada·posted 20 days ago by u/hedda_aguirre

why does nobody talk about province

Discussion

Question in the title, detail here: why does nobody talk about province.

Nothing here is medical or legal advice. The pharmacist and the prescriber are the people who can act, and both are faster than a forum.

Spent three weeks on what turned out to be a quantity limit rather than a coverage question.

Moved provinces and the coverage position changed completely. Same person, same history, different formulary.

If somebody has the same thing measured a different way, post it next to mine and we will see whether they agree.

157 up / 39 down80% upvoted13 commentsid xi1x219 Jul 2026

13 comments

13 in this archive, depth 4

best — the order this archive was captured in

u/ayesha_radich32 points·19 days ago

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.

replysharereportpermalink
u/lina_almeida-20 points·18 days ago

Push back: approval by the national regulator says nothing about whether any plan will pay.

replysharereportpermalink
u/canada_coverageMOD17 points·18 days ago

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

replysharereportpermalink
u/liv_dumitru9 points·18 days ago

Yes. Approval and coverage are separate, and this board conflates them in about half its threads.

replysharereportpermalink
u/fasting_insulin_f22 points·19 days ago

Special authorization is a documented exception process with published criteria. Applications that answer those criteria explicitly, point by point, fare better than general clinical narratives.

replysharereportpermalink
u/hedda_aguirreOP12 points·19 days ago

Those criteria were revised at renewal, so the version quoted upthread is out of date.

replysharereportpermalink
u/kian_balogun4 points·19 days ago

the criteria change at plan renewal and nobody announces it

replysharereportpermalink
u/dose_diary_danalog keeper5 points·19 days ago

Cosigning on quantity limits. They stop as many people as outright denials do and get discussed far less.

replysharereportpermalink
load more comments (5) →
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.